HealthcareServices

Global Genome-Wide Association Studies Industry Insights: Key Trends and Growth Estimates

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the genome-wide association studies market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the Genome-Wide Association Studies Market be in 2030 compared with 2026?

The genome-wide association studies market has seen rapid expansion over recent years. This market is projected to expand from $2.27 billion in 2025 to reach $2.58 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 13.7%. Historically, this expansion has been driven by factors such as the broadening of genetic research initiatives, the greater accessibility of genomic datasets, an increase in academic population studies, the growing uptake of genotyping technologies, and enhancements in data analysis capabilities.

The genome-wide association studies market is poised for substantial expansion over the next few years. It is projected to achieve a size of $4.26 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.4%. This growth during the forecast period is driven by factors such as the escalating demand for precision medicine insights, increasing investments in genomic analytics platforms, the broader application of AI-driven genetic research, rising pharmaceutical interest in target discovery, and a heightened focus on predictive healthcare models. Prominent trends anticipated in the coming years include a greater adoption of large-scale population genomics studies, the increasing utilization of advanced bioinformatics platforms, the growing incorporation of GWAS into drug discovery, the expansion of personalized medicine research programs, and an enhanced emphasis on disease risk prediction.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28234&type=smp

What Drivers Are Guiding Growth Patterns In The Genome-Wide Association Studies Market?

The rising need for personalized medicine is projected to fuel the expansion of the genome-wide association studies market in the coming years. Personalized medicine involves a medical strategy that customizes treatment and prevention plans based on an individual’s distinct genetic makeup, lifestyle, and environment. The growing embrace of personalized medicine is largely attributed to innovations in genomics, which facilitate the accurate identification of genetic variations and customized treatments for individuals. Genome-wide association studies (GWAS) bolster personalized medicine by pinpointing genetic variations associated with diseases, thereby enabling focused treatment approaches. These studies enhance healthcare results by offering insights into individual risk profiles and supporting precision therapies. For instance, in February 2024, as per the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) sanctioned 26 new personalized medicines in 2023, marking a substantial rise from the 12 approved in 2022. Consequently, the escalating demand for personalized medicine is propelling the growth of the genome-wide association studies market.

How Is The Genome-Wide Association Studies Market Divided Into Segments?

The genome-wide association studies market covered in this report is segmented –

1) By Product Type: Genotyping Services, Genotyping Kits And Reagents, Software And Data Analysis Tools, Other Product Types

2) By Application: Drug Discovery, Disease Risk Assessment, Personalized Medicine, Other Applications

3) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Hospitals And Clinics, Other End-Users

Subsegments:

1) By Genotyping Services: Whole Genome Sequencing (Wgs), Exome Sequencing, Targeted Genotyping

2) By Genotyping Kits And Reagents: Dna Extraction Kits, Sequencing Reagents, Library Preparation Kits

3) By Software And Data Analysis Tools: Bioinformatics Platforms, Data Visualization Tools, Statistical Analysis Software

4) By Other Product Types: Sample Collection Devices, Quality Control Tools, Laboratory Consumables

What Long-Term Trends Are Expected To Shape The Future Of The Genome-Wide Association Studies Market?

Leading companies in the genome-wide association studies market are concentrating on developing innovative solutions, such as advanced research platforms, to accelerate disease discovery and personalized medicine applications. An advanced research platform functions as an integrated system of tools and technologies that facilitates large-scale genomic data generation, analysis, and interpretation specifically for genome-wide association studies. For example, in January 2025, 23andMe Holding Co., a US-based biotechnology company, unveiled Discover23, a platform designed for consumers to obtain genetic insights and explore their ancestry. This platform allows biopharma collaborators to access comprehensive genetic data within a trusted environment supported by Lifebit. It offers analysis-ready genome-wide association studies (GWAS) across more than 1,000 disease cohorts, generated from billions of phenotypic data points collected from millions of consenting participants. The advanced research platform aims to speed up drug discovery by assisting researchers in identifying new disease biology and potential drug targets, and by improving clinical trial success rates, all while maintaining the privacy of participants.

Which Major Industry Participants Are Leading The Genome-Wide Association Studies Market Growth?

Major companies operating in the genome-wide association studies market are F. Hoffmann-La Roche AG, AstraZeneca plc, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Regeneron Pharmaceuticals Inc., Eurofins Scientific SE, Laboratory Corporation of America Holdings, Daiichi Sankyo Company Limited, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Databricks Inc., Broad Institute of MIT and Harvard, BGI Genomics Co. Ltd., deCODE genetics Inc., Genomics England Ltd., CD Genomics Inc., Veritas Genetics Inc., Finngen, The Wellcome Sanger Institute

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/genome-wide-association-studies-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Genome-Wide Association Studies Market?

North America was the largest region in the genome-wide association studies market in 2025. The regions covered in the genome-wide association studies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Genome-Wide Association Studies Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28234&type=smp

Browse Through More Reports Similar to the Global Genome-Wide Association Studies Market 2026, By The Business Research Company

Consumer Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/consumer-genomics-global-market-report

Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Genomics Personalized Health Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-personalized-health-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795